Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Triple nucleoside reverse transcriptase inhibitor therapy in children.

Jennifer Handforth1, Mike Sharland

  • 1Paediatric Infectious Diseases Unit, St George's Hospital, Tooting, London, UK.

Paediatric Drugs
|June 2, 2004
PubMed
Summary

Highly active antiretroviral therapy (HAART) has advanced HIV treatment, but adherence challenges persist in children. Simpler triple nucleoside reverse transcriptase inhibitor (NRTI) regimens offer potential benefits but require careful consideration due to virologic control concerns.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antiseptic Cleansing to Reduce Vertical Transmission of Pathogens to Neonates: The NeoVT-AMR Randomized Clinical Trial.

JAMA network open·2026
Same author

AWaRe antibiotic prescribing for common acute infections in private primary care in low-middle-income countries: a patient-level analysis using IQVIA prescriber surveys from Pakistan, Egypt and Indonesia.

BMJ global health·2026
Same author

Antibiotic surveillance: an action-oriented integrated approach.

Wellcome open research·2026
Same author

Alignment of national standard treatment guidelines with WHO AWaRe recommendations for adult primary care infectious diseases: implications for antimicrobial stewardship.

The Journal of antimicrobial chemotherapy·2026
Same author

Developing AWaRe-ness in primary care across low- and middle-income countries - a vital challenge for antibiotic stewardship programs.

Expert review of anti-infective therapy·2026
Same author

Pharmacokinetics and safety of fosfomycin and flomoxef administered as part of neonatal sepsis treatment (NeoSep1 Part 1).

Antimicrobial agents and chemotherapy·2025

Area of Science:

  • Pediatric infectious diseases
  • Antiretroviral therapy
  • HIV/AIDS treatment

Background:

  • HIV therapy success relies on combination drug regimens and potent new drugs like protease inhibitors.
  • Pediatric HIV treatment guidelines are regularly updated by expert panels.
  • Current preferred regimens (HAART) involve two nucleoside reverse transcriptase inhibitors (NRTIs) plus a non-nucleoside reverse transcriptase inhibitor (NNRTI) or protease inhibitor.

Purpose of the Study:

  • To evaluate the efficacy and challenges of current and alternative antiretroviral therapy regimens in pediatric HIV patients.
  • To explore the potential of simplified triple NRTI regimens in pediatric HIV management.
  • To address adherence issues and optimize long-term treatment outcomes.

Main Methods:

Related Experiment Videos

  • Review of published recommendations and clinical trial data for pediatric HIV therapy.
  • Analysis of highly active antiretroviral therapy (HAART) regimens, including their benefits and drawbacks.
  • Evaluation of triple NRTI regimens, considering simplicity, tolerability, and potential virologic control.

    • Main Results:

    • HAART regimens face challenges with drug formulation, adverse effects, and adherence in children, leading to virologic failure.
    • Triple NRTI regimens offer simplicity, good tolerability, and fewer drug interactions, but abacavir hypersensitivity is a concern.
    • Studies suggest triple NRTI therapy may have inferior virologic control compared to other regimens, limiting its general use.

    Conclusions:

    • Regimen simplification, such as triple NRTI therapy, could improve adherence and tolerability in pediatric HIV patients.
    • Despite advantages, triple NRTI regimens should be used cautiously due to potential virologic control limitations and abacavir hypersensitivity.
    • Further research and careful patient selection are necessary to optimize simplified regimens for long-term HIV management in children.